Takeda Pharmaceutical (TAK) Invested Capital (2018 - 2025)
Takeda Pharmaceutical (TAK) has 8 years of Invested Capital data on record, last reported at $49.1 billion in Q1 2025.
- For Q1 2025, Invested Capital fell 40.0% year-over-year to $49.1 billion; the TTM value through Mar 2025 reached $49.1 billion, down 40.0%, while the annual FY2025 figure was $49.1 billion, 41.52% down from the prior year.
- Invested Capital reached $49.1 billion in Q1 2025 per TAK's latest filing, down from $81.8 billion in the prior quarter.
- Across five years, Invested Capital topped out at $92.7 billion in Q1 2021 and bottomed at $49.1 billion in Q1 2025.
- Average Invested Capital over 5 years is $78.2 billion, with a median of $81.8 billion recorded in 2024.
- Peak YoY movement for Invested Capital: skyrocketed 109.27% in 2021, then crashed 40.0% in 2025.
- A 5-year view of Invested Capital shows it stood at $92.7 billion in 2021, then dropped by 6.92% to $86.3 billion in 2022, then dropped by 5.94% to $81.2 billion in 2023, then grew by 0.73% to $81.8 billion in 2024, then plummeted by 40.0% to $49.1 billion in 2025.
- Per Business Quant database, its latest 3 readings for Invested Capital were $49.1 billion in Q1 2025, $81.8 billion in Q1 2024, and $81.2 billion in Q1 2023.